NCT02060968已完成不适用
Evaluation of Effectiveness and Safety of Promus PREMIER in Routine Clinical Practice; A Multicenter, Phase-IV, Prospective Observational Study
Seung-Jung Park25 个研究点 分布在 1 个国家目标入组 2,006 人开始时间: 2014年8月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,006
- 试验地点
- 25
- 主要终点
- Composite event rate
研究概览
简要总结
The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 20 and more
- •Intervention with Promus PREMIER everolimus eluting coronary stent
- •Agreed with written informed consent form
排除标准
- •Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
- •Life expectancy of 1year and under
- •Cardiac shock
结局指标
主要结局
Composite event rate
时间窗: 1year
Death, non fatal myocardial infarction, Target Vessel Revascularization
次要结局
- Stroke(5year)
- All death(5year)
- Cardiac death(5year)
- Target Vessel revascularization(5year)
- Myocardial infarction(5year)
- Composite event of cardiac death or myocardial infarction(5year)
- Target lesion revascularization(5year)
- Composite event of death or myocardial infarction(5year)
- Stent thrombosis by an Academic Research Consortium (ARC) criteria(5year)
- Procedural success(3day)
研究者
Seung-Jung Park
MD,PhD
Asan Medical Center
研究点 (25)
Loading locations...
相似试验
已完成
不适用
Evaluation of Effectiveness and Safety of PROMUS Element Stent (IRIS-ELEMENT )Coronary Artery DiseaseNCT01350791Seung-Jung Park3,001
已完成
3 期
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)Coronary Artery DiseaseNCT01500434Boston Scientific Corporation102
已完成
不适用
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsCoronary Artery DiseaseNCT01498692Boston Scientific Corporation94
已完成
3 期
PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)Coronary Artery DiseaseNCT01510327Boston Scientific Corporation22
已完成
3 期
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery LesionsCoronary Artery DiseaseNCT00823212Boston Scientific Corporation1,530